Jin-Yu Huang1, Ying-Ying Xu2, Zhe Sun1, Zhen-Ning Wang1, Zhi Zhu1, Yong-Xi Song1, Yang Luo3, Xue Zhang3, Hui-Mian Xu1. 1. Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, China. 2. Department of Breast Surgery, First Affiliated Hospital of China Medical University, Shenyang, China. Electronic address: lovecmustar@163.com. 3. The Research Center for Medical Genomics and MOH Key Laboratory of Cell Biology, China Medical University, Shenyang City, China.
Abstract
BACKGROUND: The aberrant expression of junctional adhesion molecule A (JAM-A), which has a close correlation with the development, progression, metastasis, and prognosis of cancer, has been frequently reported. However, neither JAM-A expression nor its correlation with clinicopathologic variables and patient survival has been defined in gastric cancers. Moreover, little is known about the role of JAM-A in gastric cancer progression. We carried out the present study to investigate the prognostic value of JAM-A expression in gastric cancer patients. Furthermore, the biological roles of JAM-A in gastric cancer progression were also investigated. METHODS: We determined JAM-A expression in 167 primary gastric cancer tissues and 94 matched adjacent non-tumor tissues by immunohistochemistry. Transwell migration assays and matrigel invasion assays were used to explore the role of JAM-A in gastric cancer cells migration and invasion. CCK-8 assays were used to examine the effect of JAM-A on the proliferation of gastric cancer cells. RESULTS: JAM-A was downregulated in gastric cancer tissues. Low JAM-A expression was significantly associated with tumor size, lymphatic vessel invasion, lymph node metastasis, and TNM stage. Low JAM-A expression was also significantly associated with poor disease-specific survival in gastric cancer patients. Multivariate analysis demonstrated low JAM-A expression as an independent factor predicting poor survival. In addition, JAM-A had the effect on inhibition of gastric cancer cells migration and invasion. However, JAM-A had no significant effects on proliferation of gastric cancer cells. CONCLUSIONS: Low JAM-A expression correlates with poor clinical outcome and promotes cell migration and invasion in gastric cancer.
BACKGROUND: The aberrant expression of junctional adhesion molecule A (JAM-A), which has a close correlation with the development, progression, metastasis, and prognosis of cancer, has been frequently reported. However, neither JAM-A expression nor its correlation with clinicopathologic variables and patient survival has been defined in gastric cancers. Moreover, little is known about the role of JAM-A in gastric cancer progression. We carried out the present study to investigate the prognostic value of JAM-A expression in gastric cancerpatients. Furthermore, the biological roles of JAM-A in gastric cancer progression were also investigated. METHODS: We determined JAM-A expression in 167 primary gastric cancer tissues and 94 matched adjacent non-tumor tissues by immunohistochemistry. Transwell migration assays and matrigel invasion assays were used to explore the role of JAM-A in gastric cancer cells migration and invasion. CCK-8 assays were used to examine the effect of JAM-A on the proliferation of gastric cancer cells. RESULTS:JAM-A was downregulated in gastric cancer tissues. Low JAM-A expression was significantly associated with tumor size, lymphatic vessel invasion, lymph node metastasis, and TNM stage. Low JAM-A expression was also significantly associated with poor disease-specific survival in gastric cancerpatients. Multivariate analysis demonstrated low JAM-A expression as an independent factor predicting poor survival. In addition, JAM-A had the effect on inhibition of gastric cancer cells migration and invasion. However, JAM-A had no significant effects on proliferation of gastric cancer cells. CONCLUSIONS: Low JAM-A expression correlates with poor clinical outcome and promotes cell migration and invasion in gastric cancer.
Authors: Carmel M O'Brien; Hun S Chy; Qi Zhou; Shiri Blumenfeld; Jack W Lambshead; Xiaodong Liu; Joshua Kie; Bianca D Capaldo; Tung-Liang Chung; Timothy E Adams; Tram Phan; John D Bentley; William J McKinstry; Karen Oliva; Paul J McMurrick; Yu-Chieh Wang; Fernando J Rossello; Geoffrey J Lindeman; Di Chen; Thierry Jarde; Amander T Clark; Helen E Abud; Jane E Visvader; Christian M Nefzger; Jose M Polo; Jeanne F Loring; Andrew L Laslett Journal: Stem Cells Date: 2017-01-19 Impact factor: 6.277
Authors: Ann Mari Rosager; Mia D Sørensen; Rikke H Dahlrot; Henning B Boldt; Steinbjørn Hansen; Justin D Lathia; Bjarne W Kristensen Journal: J Neurooncol Date: 2017-07-04 Impact factor: 4.130